Nemaura Medical Inc. (NASDAQ: NMRD) Publishes 3QFY2022 Results; Company Reports its Inaugural Quarterly Revenues
Nemaura Medical has recently reported its 3QFY2022 (4QCY2021) results, with the company recognizing its inaugural revenues of $183,628 over the quarter The company also announced that it held $23 million in cash reserves as of the end of the quarter, which should amply cover its cash requirements over the coming months Nemaura Medical seized upon the opportunity to update investors on their ongoing operational highlights, which include the appointment of Dr. Arash Ghadar as COO, the formal launch of their Miboko product line Finally, the company also announced a new investment received from Tiger Partners Trading LLC, an investment advisor…